The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
Open accessAbstract
Deep brain stimulation (DBS) is associated with significant improvement of motor complications in patients with severe Parkinson's disease after some 6-12 months of treatment. Long-term results in a large number of patients have been reported only from a single study centre. We report 69 Parkinson's disease patients treated with bilateral DBS of the subthalamic nucleus (STN, n = 49) or globus pallidus internus (GPi, n = 20) included in a multicentre study. Patients were assessed preoperatively and at 1 year and 3-4 years after surgery. The primary outcome measure was the change in the 'off' medication score of the Unified Parkinson's Disease Rating Scale motor part (UPDRS-III) at 3-4 years. Stimulation of the STN or GPi induced a significant improvement (50 and 39%; P < 0.0001) of the 'off' medication UPDRS-III score at 3-4 years with respect to baseline. Stimulation improved cardinal features and activities of daily living (ADL) (P < 0.0001 and P < 0.02 for STN and GPi, respectively) and prolonged the 'on' time spent with good mobility without dyskinesias (P < 0.00001). Daily dosage of levodopa was significantly reduced (35%) in the STN-treated group only (P < 0.001). Comparison of the improvement induced by stimulation at 1 year with 3-4 years showed a significant worsening in the 'on' medication motor states of the UPDRS-III, ADL and gait in both STN and GPi groups, and speech and postural stability in the STN-treated group. Adverse events (AEs) included cognitive decline, speech difficulty, instability, gait disorders and depression. These were more common in patients treated with DBS of the STN. No patient abandoned treatment as a result of these side effects. This experience, which represents the first multicentre study assessing the long-term efficacy of either STN or GPi stimulation, shows a significant and substantial clinically important therapeutic benefit for at least 3-4 years in a large cohort of patients with severe Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,249
Self-citationUneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853
Self-citationLevodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
Limousin, P., Pollak, P., Benazzouz, A., Hoffmann, D., Le Bas, J.-F., Perret, J. E., Benabid, A.-L., & Broussolle, E. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90062-4 · Cited by 1,392
Self-citationBenabid, A. L., Pollak, P., Louveau, A., Henry, S., & de Rougemont, J. (1987) · Stereotactic and Functional Neurosurgery · doi:10.1159/000100803 · Cited by 1,378
Self-citationThe primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
Bergman, H., Wichmann, T., Karmon, B., & DeLong, M. R. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.72.2.507 · Cited by 1,365
Cited by
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944
Self-citationPallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Follett, K. A., Weaver, F. M., Stern, M., Hur, K., Harris, C. L., Luo, P., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907083 · Cited by 1,355
Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease
Benabid, A. L., Chabardes, S., Mitrofanis, J., & Pollak, P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70291-6 · Cited by 1,285
Self-citationDeep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues
Bronstein, J. M., Tagliati, M., Alterman, R. L., Lozano, A. M., Volkmann, J., Stefani, A., Horak, F. B., Okun, M. S., Foote, K. D., Krack, P., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.260 · Cited by 971
Self-citationThe scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Greenberg, B. D., Gabriels, L. A., Malone, D. A., Rezai, A. R., Friehs, G. M., Okun, M. S., Shapira, N. A., Foote, K. D., Cosyns, P. R., Kubu, C. S., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.55 · Cited by 867
Stefani, A., Lozano, A. M., Peppe, A., Stanzione, P., Galati, S., Tropepi, D., Pierantozzi, M., Brusa, L., Scarnati, E., & Mazzone, P. (2007) · Brain · doi:10.1093/brain/awl346 · Cited by 807
Self-citationOdekerken, V. J., van Laar, T., Staal, M. J., Mosch, A., Hoffmann, C. F., Nijssen, P. C., Beute, G. N., van Vugt, J. P., Lenders, M. W., Contarino, M. F., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70264-8 · Cited by 763
Self-citationFunctional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
Obeso, J. A., Rodríguez-Oroz, M. C., Benitez-Temino, B., Blesa, F. J., Guridi, J., Marin, C., & Rodriguez, M. (2008) · Movement Disorders · doi:10.1002/mds.22062 · Cited by 663
Self-citationOkun, M. S., Fernandez, H. H., Wu, S. S., Kirsch‐Darrow, L., Bowers, D., Bova, F., Suelter, M., Jacobson, C. E., Wang, X., Gordon, C. W., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21596 · Cited by 545
Plaha, P. (2006) · Brain · doi:10.1093/brain/awl127 · Cited by 515
Parsons, T. D., Rogers, S. A., Braaten, A. J., Woods, S. P., & Tröster, A. I. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70475-6 · Cited by 500
Moro, E., Lozano, A. M., Pollak, P., Agid, Y., Rehncrona, S., Volkmann, J., Kulisevsky, J., Obeso, J. A., Albanese, A., Hariz, M. I., et al. (2010) · Movement Disorders · doi:10.1002/mds.22735 · Cited by 468
Self-citationBilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease
Plaha, P., & Gill, S. S. (2005) · NeuroReport · doi:10.1097/01.wnr.0000187637.20771.a0 · Cited by 457
Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation
Castrioto, A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.182 · Cited by 455
Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes
Weaver, F. M., Follett, K. A., Stern, M., Luo, P., Harris, C. L., Hur, K., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825dcdc1 · Cited by 452
Fenoy, A. J., & Simpson, R. K. (2014) · Journal of Neurosurgery · doi:10.3171/2013.10.jns131225 · Cited by 449
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
Fasano, A., Daniele, A., & Albanese, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70049-2 · Cited by 437
Self-citationUnilateral pedunculopontine stimulation improves falls in Parkinson's disease
Moro, E., Hamani, C., Poon, Y.-Y., Al-Khairallah, T., Dostrovsky, J. O., Hutchison, W. D., & Lozano, A. M. (2010) · Brain · doi:10.1093/brain/awp261 · Cited by 427
Self-citationDeep brain stimulation: Neuropsychological and neuropsychiatric issues
Voon, V., Kubu, C., Krack, P., Houeto, J.-L., & Tröster, A. I. (2006) · Movement Disorders · doi:10.1002/mds.20963 · Cited by 403
Self-citationLópez-Azcárate, J., Tainta, M., Rodríguez-Oroz, M. C., Valencia, M., González, R., Guridi, J., Iriarte, J., Obeso, J. A., Artieda, J., & Alegre, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5459-09.2010 · Cited by 388
Self-citationSTN-DBS frequency effects on freezing of gait in advanced Parkinson disease
Moreau, C., Defebvre, L., Destée, A., Bleuse, S., Clement, F., Blatt, J. L., Krystkowiak, P., & Devos, D. (2008) · Neurology · doi:10.1212/01.wnl.0000303972.16279.46 · Cited by 385
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease
Alonso-Frech, F. (2006) · Brain · doi:10.1093/brain/awl103 · Cited by 358
Ferreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D., Deuschl, G., Dietrichs, E., Fabbrini, G., Friedman, A., Kanovsky, P., et al. (2013) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03866.x · Cited by 348
Current approaches to the treatment of Parkinson’s disease
Jankovic, J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2006 · Cited by 342
Deep Brain Stimulation for Neurologic and Neuropsychiatric Disorders
Wichmann, T., & DeLong, M. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.022 · Cited by 331
A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD
St. George, R. J., Nutt, J. G., Burchiel, K. J., & Horak, F. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f61329 · Cited by 305
Miocinovic, S., Parent, M., Butson, C. R., Hahn, P. J., Russo, G. S., Vitek, J. L., & McIntyre, C. C. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00305.2006 · Cited by 305
Minimal clinically important change on the unified Parkinson's disease rating scale
Schrag, A., Sampaio, C., Counsell, N., & Poewe, W. (2006) · Movement Disorders · doi:10.1002/mds.20914 · Cited by 297
Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., Kanovsky, P., Larsen, J. P., Lees, A., Oertel, W., Poewe, W., et al. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01547.x · Cited by 297
Stimulating at the right time: phase-specific deep brain stimulation
Cagnan, H., Pedrosa, D., Little, S., Pogosyan, A., Cheeran, B., Aziz, T., Green, A., Fitzgerald, J., Foltynie, T., Limousin, P., et al. (2017) · Brain · doi:10.1093/brain/aww286 · Cited by 270
Self-citationReview: Deep brain stimulation in Parkinson’s disease
Groiss, S. J., Wojtecki, L., Südmeyer, M., & Schnitzler, A. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609339382 · Cited by 280
Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study
Smeding, H. M. M., Speelman, J. D., Koning-Haanstra, M., Schuurman, P. R., Nijssen, P., van Laar, T., & Schmand, B. (2006) · Neurology · doi:10.1212/01.wnl.0000234881.77830.66 · Cited by 272
Self-citationEmerging technologies for improved deep brain stimulation
Cagnan, H., Denison, T., McIntyre, C., & Brown, P. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0244-6 · Cited by 272
Bilateral stimulation of the caudal zona incerta nucleus for tremor control
Plaha, P., Khan, S., & Gill, S. S. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.112334 · Cited by 267
First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease
Magara, A., Bühler, R., Moser, D., Kowalski, M., Pourtehrani, P., & Jeanmonod, D. (2014) · Journal of Therapeutic Ultrasound · doi:10.1186/2050-5736-2-11 · Cited by 263
Deep brain stimulation for Parkinson's disease
Hariz, M., & Blomstedt, P. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13541 · Cited by 256
Self-citationDystonia in Parkinson’s disease
Tolosa, E., & Compta, Y. (2006) · Journal of Neurology · doi:10.1007/s00415-006-7003-6 · Cited by 176
Current applications and limitations of surgical treatments for movement disorders
Krack, P., Martinez‐Fernandez, R., del Alamo, M., & Obeso, J. A. (2017) · Movement Disorders · doi:10.1002/mds.26890 · Cited by 122
“…77.2 50 Odekerken et al (2016)43 63 3 years 31.7 ND ND ND 51.7 ND GPi-DBS studies Volkmann et al (2004)58 11 5 years 27.9 83 70a ND 21 12 29 47.6 Rodriguez-Oroz et al (2005)48 20 3-4 years 39 45 72a ND Unchanged 29.5 85 38 Moro et al (2010)53 16 5-6 years 35.6 ND 71a ND 16 23.5 65.5 41.7 Weaver…”
InfluentialSelf-citationFuentes, R., Petersson, P., & Nicolelis, M. A. L. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07417.x · Cited by 85
Deep brain stimulation: current and future perspectives
Awan, N. R., Lozano, A., & Hamani, C. (2009) · Neurosurgical Focus · doi:10.3171/2009.4.focus0982 · Cited by 83
Self-citationPothof, F., Bonini, L., Lanzilotto, M., Livi, A., Fogassi, L., Orban, G. A., Paul, O., & Ruther, P. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/4/046006 · Cited by 56
Anxiolytic drug discovery: What are the novel approaches and how can we improve them?
Stewart, A. M., & Kalueff, A. V. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.857309 · Cited by 22
“Notable for causing fewer side effects than pharmacological approaches, direct brain or nerve stimulation is increasingly being used for not only the treatment of motor disorders such as Parkinson’s disease [150,151] and Tourette’s syndrome [152,153], but also affective disorders (such as anxiety [17,154] or depressio…”
BackgroundNeurophysiological considerations for visual implants
Meikle, S. J., & Wong, Y. T. (2022) · Brain Structure and Function · doi:10.1007/s00429-021-02417-2 · Cited by 15
(2012) · doi:10.1044/1058-0360(2012/11-0125
Metadata
- Authors
- Rodriguez-Oroz, M. C., Obeso, J. A., Lang, A. E., Houeto, J.-L., Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M. I., Quinn, N. P., Speelman, J. D., Guridi, J., Zamarbide, I., Gironell, A., Molet, J., Pascual-Sedano, B., Pidoux, B., Bonnet, A. M., Agid, Y., Xie, J., Benabid, A.-L., Lozano, A. M., Saint-Cyr, J., Romito, L., Contarino, M. F., Scerrati, M., Fraix, V., & Van Blercom, N.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-23
- Volume
- 128
- Issue
- 10
- Pages
- 2240-2249
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2124227727
- Cited by
- 1,057
- References
- 43
- FWCI
- 42.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.